SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-19-017156
Filing Date
2019-11-14
Accepted
2019-11-14 07:01:00
Documents
33
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 476036
  Complete submission text file 0001493152-19-017156.txt   1458365

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE vblt-20190930.xml EX-101.INS 115937
3 XBRL SCHEMA FILE vblt-20190930.xsd EX-101.SCH 26881
4 XBRL CALCULATION FILE vblt-20190930_cal.xml EX-101.CAL 41756
5 XBRL DEFINITION FILE vblt-20190930_def.xml EX-101.DEF 39779
6 XBRL LABEL FILE vblt-20190930_lab.xml EX-101.LAB 160930
7 XBRL PRESENTATION FILE vblt-20190930_pre.xml EX-101.PRE 98096
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 191216289
SIC: 2834 Pharmaceutical Preparations